Skip to main content
. 2021 Feb 24;35:2058738421990952. doi: 10.1177/2058738421990952

Table 1.

Parameters and characteristics of patients and controls.

Severe asthmatics (SA) Non-severe asthmatics (NSA) Healthy subjects (HS)
(n) 14 18 14
Age 47 38 43
Gender F/M 8/6 10/8 8/6
Atopic to Der p1 14 18 0
FEV1 baseline (%) 47.7*# 91.6 107.1
FEV1 max (%) 66.4* 98.7
Cluster 4–5 1–2
WBC (g/l) 8.1 6.7 6.7
NE (%) 56.3 55.6 55.7
LIMF (%) 26.4 32.4 33.6
MO (%) 8.4 7.7 7.5
EOS (%) 7.9 3.6 2.6
BASO (%) 1 0.7 0.6
HGB (g/dl) 14.3 14.2 13.8
PLT (g/l) 275.9 260.8 262.7
CRP (mg/l) 4.3 2.5 2.2
Glucocorticoids use High low n.a

FEV1: forced expiratory volume; WBC: white blood cells; NE: neutrophils; LIMF: lymphocytes; MO: monocytes; EOS: eosinophils; BASO: basophils; HGB: hemoglobin; PLT: platelets; CRP: C reactive protein.

*

P < 0.05 in comparison to non-severe asthmatics.

#

P < 0.05 in comparison to healthy subjects.